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Abstract
We report a 20-year-old female with sickle cell anaemia and with an HbF
concentration of 15.8%. The patient was not using hydroxyurea and was not
receiving regular blood transfusions. The patient never had chronic
manifestations of sickle cell anaemia, only pain crises of a mild intensity. After
laboratory tests, we found that she was homozygous for HbS with the
Bantu/atypical haplotype, and was heterozygous for the XmnI site. The influence
of the XmnI site on the expression of HbF can explain the amelioration in clinical
features in this haplotype association in a case of sickle cell anaemia.
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Introduction
Sickle cell anaemia (SCA) is a genetic disorder characterized by
a multifaceted pathophysiology that involves changes in erythrocytes,
vaso-occlusive processes, chronic inflammatory states, oxidative stress
and endothelial dysfunction. Therefore, there is decreased blood flow and
obstruction of the microcirculation, which leads to a variety of clinical
complications [1].
The reasons for this heterogeneity are not fully understood; however,
fetal haemoglobin (HbF) is the best-known and most frequently studied
genetic regulator of SCA, because it inhibits HbS polymerization. The
individual variation in HbF levels is probably one of the main factors
contributing to the clinical heterogeneity observed in these patients [2].
We considered the genotype of SCA and the haplotypes of the beta
globin gene cluster in 50 patients with clinical features of sickle cell disease
from the Sa ~o Paulo state, south-eastern Brazil. We found one patient 
with HbF levels above the expected and reported values. The presence of
the XmnI polymorphic site in the 5' Gγ gene influences HbF expression,
and a few studies have been conducted to explain the genetic factors
involved in HbF levels in genetically mixed populations, such as that of
Brazil. We evaluated the XmnI site and correlated it with HbF values,
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Case report
This study analyses a 20-year-old woman of
African descent, diagnosed with SCA through
electrophoresis tests. She was receiving clinical
follow-up care at the Blood Centre of the Santa
Casa Medical School in Sa ~o Paulo, Brazil. She was
not receiving hydroxyurea, or any other drug that
induces the expression of HbF. She was not
receiving regular blood transfusions, and the only
medication in use was folic acid. 
According to the haematological data of the
patient, she presented with: RBC (2.6 × 106/µl), Hb
(7.8 g/dl), Hct (24%), MCV (94.1 fl), MCH (28.9 pg),
WBC (8.3 × 103 mm3), neutrophil (61.3%), lymphocyte
(19.0%), monocyte (3.0%), eosinophil (2.2%), platelet
(539 103 mm3), reticulocyte (10.8%).
The patient never had any chronic manifes  -
tations of sickle cell disease, such as leg ulcers,
osteonecrosis, retinopathy, stroke, cholecystectomy
or acute chest syndrome. But in the 3 years prior
to our study, she had 5 painful crises with mild
intensity that did not require hospitalization.
After the patient gave her consent to participate
in this study, we collected blood samples and
performed tests.
In order to characterize the genotype of sickle
cell disease, we performed cytological tests,
electrophoresis in alkaline pH, acid pH and neutral
pH, high performance liquid chromatography (HPLC)
(VARIANTTM, Bio-Rad Laboratories, CA, USA) and
molecular analysis using PCR-RFLP . Next, the
amplificated fragment was digested using the
FastDigestTM DdeI restriction enzyme (Fermentas,
ON, CA) [3]. Haplotypes were determined through
the analysis of the following polymorphic restriction
sites: Gγ (HindIII), Aγ (HindIII), ψβ (HincII), 3’ψβ
(HincII) e 5’β (HinfI), following Sutton et al. [4].
The identification of the polymorphic XmnI site
in Gγ (rs7482144) was performed through PCR,
followed by restriction analysis using the XmnI
enzyme (New England Biolabs) [4].
The test results are shown in Table I. According
to the genotype of sickle cell disease, the patient
was homozygous for HbS, and she had not
inherited the α-thalassaemia gene. Her HbF
concentration was 15.8%. Because the presence of
the XmnI site was observed in only one allele, we
investigated other polymorphic sites to verify
whether the SNP patterns presented were related
to haplotypes listed in the literature. 
Based on these findings, we concluded that the
patient was HbSS positive with the Bantu/atypical
haplotype (+ – – + + –). The atypical allele has
a combination of individual polymorphic sites that
do not fit the classification described in the
literature, 5’ Gγ (XmnI) = +, Gγ (HindIII) = –, Aγ
(HindIII) = –, ψβ (HincII) = +, 3’ ψβ (HincII) = +, 5’β
(HinfI) = –.
Discussion
The association between the XmnI
polymorphism (rs7482144) in the proximal promoter
of the Gγ-globin gene and HbF levels is well
documented in sickle cell disease patients. In 1985,
a polymorphism (C/T at position –158 of Gγ-globin,
later named XmnI-HBG2 or rs7482144), was
TestR esult Normal values Method
Chromatography analysis SF AA Eastman
Alkaline pH electrophoresis SF AA Marengo & Rowe
Acid pH electrophoresis SF AA Vella
Neutral pH electrophoresis Absent Absent Dacie & Lewis
Erythrocyte morphology ++ Normocytosis Bonini-Domingos
Heinz inclusion bodies Absent Absent Papayannopoulos
HbH inclusion bodies Absent Absent Papayannopoulos
Quantification of HbA2 2.30% 2.5–3.5% HPLC
Quantification of HbF 15.80% 0–1.0% HPLC
Quantification of HbS 83.80% 0% HPLC
Osmotic resistance Negative Negative Silverstoni & Bianco
Sickling test Present Absent Dacie & Lewis
Solubility test (HbS) Positive Negative Itano
Molecular analysis HbS SS absence of mutation PCR-RFLP
–158 (C → T) 5’ Gγ (XmnI) (+/–) – PCR-RFLP
Table I. Laboratory tests performed to characterize the haemoglobin profile
SF – homozygous of HbS (sickle cell anaemia + HbF), AA – homozygous of HbA (normal adult), SS – homozygous of HbS (sickle cell anaemia)
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identified and proven to promote the expression of
Gγ-chain and to contribute to HbF variability. Other
studies in the same decade characterized SNP
patterns in and around β-globin cluster genes, and
found the βS chromosome to be associated with
five major haplotypes originating from different
geographical regions of Africa, the Middle East, and
the Indian subcontinent [5].
Of the main haplotypes, the one carrying the
Senegal and Arab-Indian characteristics exhibits the
polymorphism XmnI, and this is strongly associated
with increased levels of Hb F and, consequently,
more minimal clinical manifestations, unlike the
Bantu haplotype, which is associated with low
levels of HbF and haematocrit, and which is
clinically more severe [6].
In our study, the SCA patient carried a Bantu
allele and an atypical allele (+ – – + + –). She also
had an XmnI site, and an HbF concentration of
15.8%. Even with the low haematocrit values, the
clinical complications were minimal when compared
to other SCA patients and to those with the Bantu
haplotype.
An increase in HbF has been associated with
minimal clinical manifestations in SCA patients. Leg
ulcers are less common in patients who have high
levels of HbF [7]; the occurrence of acute chest
syndrome and the frequency of painful crises are
inversely proportional to HbF levels. Buchanan 
et al. [8] suggested an association between high HbF
levels and a low frequency of leg ulcers. Powars and
Hiti [9] and Nagel and Steinberg [10] showed that
high levels of HbF were associated with milder SCA
symptoms. They also found that a higher
expression of HbF in adulthood improves the rates
of morbidity and mortality in SCA patients [11].
These results support our observations, in which
the patient has a high level of HbF and a milder
phenotype, therefore requiring fewer blood
transfusions.
We would like to highlight that the XmnI site's
contribution to the variation in HbF levels in sickle
cell patients is low when compared in isolation;
however, Lettre et al. [12] showed that the
rs7482144 polymorphism in homozygotes
accounted for 2.2% of the variation in levels of HbF
in 1275 SCA patients from the African American
Cooperative Study of Sickle Cell Disease. However,
the sum of five different SNPs – rs4671393 in the
BCL11A gene; rs28384513, rs9399137, and rs4895441
in the intergenic region between HBSL1 and MYB
on chromosome 6; and rs7482144 in the 5' gene Gγ
– explain 20% of the variation of HbF in SCA
patients. In this study, it was not possible to
evaluate the effect of the polymorphism in the
group of patients in Brazil, because the Senegal and
Arabic-Indian haplotypes are rare in the Brazilian
population.
The polymorphism rs7482144 acts to increase
the expression of HbF. Carriers who have the XmnI
site also respond better to treatment with
hydroxyurea [13], and this shows that new drugs
can act in this region in the search for different
therapies for the treatment of SCA. 
In conclusions, the presence of the XmnI
polymorphic site (rs7482144) in patients who are
heterozygous for the 5' gene Gγ was responsible for
the increased expression of HbF. Although one of
the alleles was of the Bantu haplotype, the clinical
manifestation was minimal. These results reveal
the importance of investigating factors that
regulate HbF in sickle cell patients in a genetically
mixed population such as that of Brazil.
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